Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Payables (2022 - 2025)

Neuraxis (NRXS) has disclosed Payables for 4 consecutive years, with $176953.0 as the latest value for Q4 2025.

  • Quarterly Payables fell 5.21% to $176953.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $176953.0 through Dec 2025, down 5.21% year-over-year, with the annual reading at $176953.0 for FY2025, 5.21% down from the prior year.
  • Payables hit $176953.0 in Q4 2025 for Neuraxis, down from $232818.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $4.8 million in Q2 2024 to a low of $121991.0 in Q1 2025.
  • Historically, Payables has averaged $1.1 million across 4 years, with a median of $263221.0 in 2023.
  • Biggest five-year swings in Payables: surged 321.62% in 2024 and later plummeted 96.81% in 2025.
  • Year by year, Payables stood at $287516.0 in 2022, then dropped by 22.44% to $223009.0 in 2023, then fell by 16.29% to $186679.0 in 2024, then decreased by 5.21% to $176953.0 in 2025.
  • Business Quant data shows Payables for NRXS at $176953.0 in Q4 2025, $232818.0 in Q3 2025, and $153360.0 in Q2 2025.